• Busca persones
• Intranet

Miogènesi, inflamació i funció muscular Joaquim Gea

Publicacions 2024 (4)

• Josa-Culleré A, Basagaña X, Koch S, Arbillaga A, Balcells E, Bosch de Basea M, Celorrio N, Foraster M, Rodríguez-Roisín R, Marin A, Peralta GP, Rodríguez DA, Simonet P, Torán P, Vall-Casas P, Garcia-Aymerich J^*. Short-term effects of air pollution and weather on physical activity in patients with chronic obstructive pulmonary disease (COPD). Environ Res 2024; 247: (en Premsa).
• Caguana OA, Khilzi K, Piccari L, Rodríguez-Sevilla JJ, Badenes D, González-Garcia J, Chalela R, Arita M, Rodó A, Herranz A, Admetllo M, Villar-García J, Molina L, Zuccarino F, Gea J, Balcells E, Rodríguez DA^*. Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism in SARS-CoV-2. Respiration 2024; 103(2): 79-87.
• Piccari L, Wort SJ^*. Use of inhaled treprostinil in patients with interstitial lung disease and pulmonary hypertension: to boldly go where no other pulmonary vasodilator has gone before?. Thorax 2024; 79(4): 295-296.
• Shlobin OA^*, Shen E, Wort SJ, Piccari L, Scandurra JA, Hassoun PM, Nikkho SM, Nathan SD. Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension. Pulm Circ . 2024; 14(1): e12310 (Acceptat).